Advertisement

Aldosteron und Hochdruck

experimentelle Befunde
  • F. Gross
Part of the Neuntes Symposion der Deutschen Gesellschaft für Endokrinologie book series (ENDOKRINOLOGIE, volume 9)

Zusammenfassung

Aldosteron kann an der Pathogenese verschiedener Formen von experimentellem und von klinischem Hochdruck in folgender Weise beteiligt sein:
  1. 1.

    Als primär auslösende Noxe, entweder durch endogene Überproduktion oder in Form exogener Überdosierung. Dabei kann neben anderen Symptomen ein Hochdruck auftreten, vorausgesetzt, daß bestimmte Versuchsbedingungen eingehalten werden.

     
  2. 2.

    Als sekundärer Faktor im Sinne einer permissiven Wirkung, wobei die Anwesenheit normaler Mengen von Aldosteron genügt, um zusammen mit anderen humoralen Faktoren die Voraussetzungen für die Entwicklung oder Aufrechterhaltung eines Hochdruckes zu geben.

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    August, J. H., D. H. Nelson and G. W. Thorn: Response of normal subjects to large amounts of aldosterone. J. clin. Invest. 37, 1459 (1958).CrossRefGoogle Scholar
  2. 2.
    August, J. H., D. H. Nelson and G. W. Thorn: Adjustment to aldosterone or desoxycorticosterone acetate induced sodium retention in patients with ADDISON’S disease. J. clin. Invest. 38, 1964 (1959); Metabolism 9, 508 (1960).Google Scholar
  3. 3.
    Bartter, F. C., A. G. T. Casper, C. S. Delea and J. D. H. Slater: On the role of the kidney in control of adrenal steroid production. Metabolism 10, 1006 (1961).Google Scholar
  4. 4.
    Besch, P. K., K. A. Brownell, F A Hartman and D. J. Watson: Adrenocortical steroid profile in the hypertensive dog. Acta endocr. (Kbh.) 39, 355 (1962).Google Scholar
  5. 5.
    Brodi, M. P., and C. Pellegrino: The secretion of corticosterone and aldosterone by the rat adrenal cortex regenerating after enucleation. J. Physiol. (Lond.) 146, 165 (1959).Google Scholar
  6. 6.
    Carpenter, C. C. J., J. O. Davis and C. R. Ayers: Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion. J. clin. Invest. 40, 2026 (1961).PubMedCrossRefGoogle Scholar
  7. 7.
    Chappel, C. I., G. Rona and J. Cahill: Studies on the pathogenesis of adrenal-regeneration hypertension in the rat. Arch. Path. 65, 636 (1958).Google Scholar
  8. 8.
    Comparison of corticosterone and adrenal-regeneration hypertension. Proc. Canad. Fed. Biol. Soc. 1958, p. 12.Google Scholar
  9. 9.
    Cope, C. L., M. Harwood and J. Pearson: Aldosterone secretion in hypertensive disease. Brit. med. J. 1962 I, 659.CrossRefGoogle Scholar
  10. 10.
    Davignon, J., E. Koiw, W. Nowaczynski, G. Tremblay and J. Genest: Studies on the in vitro production of corticosteroids by adrenal glands from normotensive individuals and hypertensive patients. Canad. J. Biochem. 40, 285 (1962).PubMedCrossRefGoogle Scholar
  11. 11.
    Davis, J. O., C. C. J. Carpenter, C. R. Ayers, J. E. Holman and R. C. Bahn: Evidence for secretion of an aldosterone-stimulating hormone by the kidney. J. clin. Invest. 40, 684 (1961).PubMedCrossRefGoogle Scholar
  12. 12.
    Davis P. M. Hartroft, E. O. Titus, C. C. J. Carpenter, C. R. Ayers and H. E. Spiegel: The role of the renin-angiotensin system in the control of aldosterone secretion. J. clin. Invest. 41, 378 (1962).PubMedCrossRefGoogle Scholar
  13. 13.
    Fregly, M. J.: Production of hypertension in adrenalectomized rats given hypertonic salt solution to drink. Endocrinology 66, 240 (1960).PubMedCrossRefGoogle Scholar
  14. 14.
    Fregly, M. J. and V. M. Arean: Comparison of the effects of aldosterone and desoxycorticosterone acetate on blood pressure of rats. Acta physiol. pharmacol. neerl. 8, 162 (1959).PubMedGoogle Scholar
  15. 15.
    Gaunt, R., G. J. Ulsamer and J. J. Chart: Aldosterone and hypertension. Arch. int. Pharmacodyn. 110, 114, (1957).Google Scholar
  16. 16.
    Gaunt F. Gross, A. A. Renzi and J. J. Chart: The adrenal cortex in hypertension (with particular reference to adrenal regeneration hypertension). “Hypertension”. 1st Hahnemann Symposium on Hypertensive Disease, p. 219. Philadelphia: Saunders 1959.Google Scholar
  17. 17.
    Genest, J., W. Nowaczynski, E. Koiw, T. SANDOR and P. BIRON: Nebennierenrindenfunktion bei essentieller Hypertonie. „Essentielle Hypertonie“, p. 143. Berlin, Göttingen, Heidelberg: Springer 1960.Google Scholar
  18. 18.
    Genest, J., W. Nowaczynski, E. Koiw, T. SANDOR and P. BIRON: Angiotensin, aldosterone and human arterial hypertension. Canad. med. Ass. J. 84, 403 (1961).Google Scholar
  19. 19.
    Genest, J. P. BIRON, R. BOUCHER, E. KOIw, W. NOWACZYNSKI and M. CHRÉTIEN: Hypertension and the endocrine system. “Hypertension, recent advances.” 2nd Hahnemann Symposium on Hypertensive Disease, p. 76. Philadelphia: Lea Febiger 1961.Google Scholar
  20. 20.
    Goldblatt, H.: The renal origin of hypertension. Physiol. Rev. 27, 120 (1947).PubMedGoogle Scholar
  21. 21.
    Gornall, A. G., R. Nakashima, H. M. Grundy, C. J. Koladich and M. V. L. Rao: Further studies of aldosterone induced hypertension in rats. Proc. Endocrin. Soc., 39th Meet. 1957, p. 15.Google Scholar
  22. 22.
    Gross, F.: Experimentelle Methoden zur Beurteilung blutdrucksenkender Pharmaka. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 232, 161 (1957).Google Scholar
  23. 23.
    Gross, F.: Renin und Hypertensin, physiologische oder pathologische Wirkstoffe ? Klin Wschr. 36, 693 (1958).PubMedCrossRefGoogle Scholar
  24. 24.
    Gross, F.: Nebennierenrindenfunktion und renale Pressormechanismen bei experimenteller Hypertension. „Essentielle Hypertonie“, p. 105. Berlin, Göttingen, Heidelberg: Springer 1960.Google Scholar
  25. 25.
    Gross, O. Buschor and P. Zeugin: Renin in the kidneys of rats with aminonucleoside nephrosis. Amer. J. Physiol. 199, 1 (1960).PubMedGoogle Scholar
  26. 26.
    Gross, O., and R. HESS: Histochemical changes in kidneys and in salivary glands of rats with experimental hypertension. Proc. Soc. exp. Biol. (N. Y.) 104, 509 (1960).Google Scholar
  27. 27.
    Gross, O., and P. Lichtlen: Pressor substances in kidneys of renal hypertensive rats with and without adrenals. Proc. Soc. exp. Biol. (N. Y.) 98, 341 (1958).Google Scholar
  28. 28.
    Gross, O., and P. Lichtlen: Further evidence for a quantitative difference between aldosterone and cortexone. “Aldosterone”, p. 39. An International Symposium. London: Churchill 1958.Google Scholar
  29. 29.
    Gross, O., P. Loustalot and R. Meier: Production of experimental hypertension by aldosterone. Acta endocr. (Kbh.) 26, 417 (1957).Google Scholar
  30. 30.
    Gross, O., P. Loustalot, u. F. SULSER: Bedeutung von Kochsalz für den Cortexon-Hochdruck der Ratte und den Gehalt der Nieren an pressorischen Substanzen. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 229, 381 (1956).Google Scholar
  31. 31.
    Gross, O., and H. Scam: Aldosterone overdosage in the rabbit. Acta endocr. (Kbh.) 28, 467 (1958).Google Scholar
  32. 32.
    Gross, O. u. F. Sulser: Der Einfluß der Nebennieren auf die blutdrucksteigernde Wirkung von Renin und auf pressorische Substanzen in den Nieren. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 230, 274 (1957).Google Scholar
  33. 33.
    Hartroft, P. M., and W. S. Hartroft: Studies on renal juxtaglomerular cells: 1. Variations produced by sodium chloride and desoxycorticosterone acetate. J. exp. Med. 97, 415 (1953).PubMedCrossRefGoogle Scholar
  34. 34.
    Hartroft, P. M., and W. S. Hartroft: Studies on renal juxtaglomerular cells: 2. Correlation of degree of granulation of juxtaglomerular cells with width of zona glomerulosa of adrenal cortex. J. exp. Med. 102, 205 (1955).PubMedCrossRefGoogle Scholar
  35. 35.
    Hess, R., and F. Gross: Glucose-6-phosphate dehydrogenase and renin in kidneys of hypertensive or adrenalectomized rats. Amer. J. Physiol. 197, 869 (1959).PubMedGoogle Scholar
  36. 36.
    Kumar, D., W. Anderson and A. G. Gornall: Postmortem study of rats made hypertensive by aldosterone. J. clin. Endocr. 16, 918 (1956).Google Scholar
  37. 37.
    Laragh, J. H.: Relation of aldosterone secretion to hypertensive vascular disease. Circulat. Res. 9, 792 (1961).PubMedCrossRefGoogle Scholar
  38. 38.
    Laragh, J. H.: Interrelationships between angiotensin, norepinephrine, epinephrine, aldosterone secretion, and electrolyte metabolism in man. Circulation 25, 203 (1962).PubMedCrossRefGoogle Scholar
  39. 39.
    Laragh, J. H, S. Ulick, V. Januszewicz, Q. B. Deming, W G Kelly and S. Lieberman • Aldosterone secretion and primary and malignant hypertension. J. clin. Invest. 39, 1091 (1960).PubMedCrossRefGoogle Scholar
  40. 40.
    Laragh, J. H, M. Angers, W. G. Kelly and S. Lieberman: Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. J. Amer. med. Ass. 174, 234 (1960).CrossRefGoogle Scholar
  41. 41.
    Mulrow, P. J., W. F. Ganong, G. Cera and A. Kuljian: The nature of the aldosteronestimulating factor in dog kidneys. J. clin. Invest. 41, 505 (1962).PubMedCrossRefGoogle Scholar
  42. 42.
    Mulrow, P. J., W. F. Ganong, G. Cera and A. Kuljian: Role of the kidney and the renin-angiotensin system in the response of aldosterone secretion to hemorrhage. Circulation 25, 213 (1962).PubMedCrossRefGoogle Scholar
  43. 43.
    Neher, R.: Aldosterone and other adrenocortical hormones in human adrenals and adrenal tumours. “Aldosterone”, p. 11; an International Symposium. London: Churchill 1958.Google Scholar
  44. 44.
    Omae, T., G. M. C. Masson and I. H. PAGE: Release of pressor substances from renal grafts originating from rats with renal hypertension. Circulat. Res. 9, 441 (1961).PubMedCrossRefGoogle Scholar
  45. 45.
    Peart, W. S.: Verh. dtsch. Ges. Kreisl.-Forsch. 1962 (in press).Google Scholar
  46. 46.
    Pitcock, J. A., P. M. Hartroft and L. N. Newmark: Increased renal pressor activity (Renin) in sodium deficient rats and correlation with juxtaglomerular cell granulation. Proc. Soc. exp. Biol. (N. Y.) 100, 868 (1959).Google Scholar
  47. 47.
    Regoli, D., H. Brunner, G. Peters and F. Gross: Changes in renin content in kidneys of renal hypertensive rats. Proc. Soc. exp. Biol. (N. Y.) 109, 142 (1962).Google Scholar
  48. 48.
    Regoli, D., R. Hess, H. Brunner, G. Peters and F. Gross: Interrelationship of renin content in kidneys and blood pressure in renal hypertensive rats. Arch. in Pharmacodyn. 140, 416 (1962).Google Scholar
  49. 49.
    Ross, E. J.: Aldosterone in clinical and experimental medicine. Springfield: Thomas 1959.Google Scholar
  50. 50.
    Selye, H., and C. E. Hall: Pathologic changes induced in various species by overdosage with desoxycorticosterone. Arch. Path. 36, 19 (1943).Google Scholar
  51. 51.
    Selye, H.: Production of nephrosclerosis and cardiac hypertrophy in the rat by desoxycorticosterone acetate overdosage. Amer. Heart J. 27, 338 (1944).CrossRefGoogle Scholar
  52. 52.
    Skelton, F. R.: Adrenal regeneration and adrenal-regeneration hypertension. Physiol. Rev. 39, 162 (1959).PubMedGoogle Scholar
  53. 53.
    Slater, J. D. H., H. H. Henderson, A. C. T. Casper, B. H. Barton and F. C. Bartter: Control of adrenal cortical activity by the renin-angiotensin system with changes in renal blood flow. Clin. Res. 10, 256 (1962).Google Scholar
  54. 54.
    Smithwick, R. H., D. Kinsey and G. P. Wfutelaw: Surgical treatment of hypertension — Primary aldosteronism New Engl. J. Med. 266, 160 (1962).Google Scholar
  55. 55.
    Tobtan, L.: Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol. Rev. 40, 280 (1960).Google Scholar
  56. 56.
    Tobtan, L.: Relationship of juxtaglomerular apparatus to renin and angiotensin. Circulation 25, 189 (1962).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1963

Authors and Affiliations

  • F. Gross
    • 1
  1. 1.Forschungslaboratorien der CIBA AktiengesellschaftPharmazeutische AbteilungBaselSchweiz

Personalised recommendations